<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Controlled clinical trials of <z:chebi fb="164" ids="18723">nicotine</z:chebi> transdermal patch for treatment of <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> have been shown to improve histological and global clinical scores of <z:hpo ids='HP_0002583'>colitis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Here we report that <z:chebi fb="164" ids="18723">nicotine</z:chebi> (1 microM) suppresses in vitro hyperexcitability of colonic dorsal root ganglia (DRG) (L(1)-L(2)) neurons in the <z:chebi fb="0" ids="52071">dextran</z:chebi> <z:chebi fb="0" ids="32149">sodium sulfate</z:chebi> (DSS)-induced mouse model of <z:hpo ids='HP_0011009'>acute</z:hpo> colonic <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="164" ids="18723">Nicotine</z:chebi> gradually reduced regenerative multiple-spike action potentials in <z:hpo ids='HP_0002583'>colitis</z:hpo> mice to a single action potential </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="164" ids="18723">Nicotine</z:chebi>'s effect on hyperexcitability of inflamed neurons was blocked in the presence of an alpha(7)-nicotinic <z:chebi fb="9" ids="15355">acetylcholine</z:chebi> receptor (nAChR) <z:chebi fb="68" ids="48706">antagonist</z:chebi>, methyllicaconitine, while <z:chebi fb="3" ids="15354">choline</z:chebi>, the alpha(7)-nAChR <z:chebi fb="4" ids="48705">agonist</z:chebi>, induced a similar effect to that of <z:chebi fb="164" ids="18723">nicotine</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Consistent with these findings, <z:chebi fb="164" ids="18723">nicotine</z:chebi> failed to suppress hyperexcitability in colonic DRG neurons from DSS-treated alpha(7) knockout mice </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, colonic DRG neurons from DSS-treated alpha(7) knockout mice were characterized by lower rheobase (10 +/- 5 vs. 77 +/- 13 pA, respectively) and current threshold (28 +/- 4 vs. 103 +/- 8 pA, respectively) levels than DSS-treated C57BL/J6 mice </plain></SENT>
<SENT sid="6" pm="."><plain>An interesting observation of this study is that 8 of 12 colonic DRG (L(1)-L(2)) neurons from control alpha(7) knockout mice exhibited multiple-spike action potential firing while no <z:mp ids='MP_0002169'>wild-type</z:mp> neurons did </plain></SENT>
<SENT sid="7" pm="."><plain>Overall, our findings suggest that <z:chebi fb="164" ids="18723">nicotine</z:chebi> at low 1 microM concentration suppresses in vitro hyperexcitability of inflamed colonic DRG neurons in a mouse model of <z:hpo ids='HP_0011009'>acute</z:hpo> colonic <z:mp ids='MP_0001845'>inflammation</z:mp> via activation of alpha(7)-nAChRs </plain></SENT>
</text></document>